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Osteoarthritis (OA) is a chronic degenerative joint disorder commonly associated with metabolic syn-
drome. As ageing and obesity has a great impact on the initiation/severity of OA, herein we sought to
investigate the involvement of Sirt6 in the crosstalk between ageing and metabolic syndrome/OA. Sirt6
haploinsufﬁciency in mice promoted the expression of inﬂammatory cytokines in the IPFP. Enhanced
inﬂammation of the IPFP in the aged Sirt6 ± HFD group was paralleled with accelerated OA change,
including osteophyte growth and chondrocyte hypertrophy. Conversely, mesenchyme-speciﬁc Sirt6-
deﬁcient mice revealed both attenuated chondrocyte hypertrophy and proteoglycan synthesis,
although chondrocyte senescence was enhanced as shown in the aged WT mice. Thus Sirt6 has key roles
in the relationship among ageing, metabolic syndrome, and OA.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Metabolic syndrome is a common phenotype associated with an
increased risk of cardiovascular disease or diabetes. It is well known
that individuals suffering from metabolic syndrome display a
characteristic imbalance in their adipokine proﬁle, which leads to
profound changes in insulin sensitivity and other biochemical al-
terations of metabolites.
Osteoarthritis (OA) is a chronic degenerative joint disorder
characterized by articular cartilage destruction and osteophyte
formation. Obesity and high body mass index are associated with a
higher incidence of OA [1,2]. Recent studies have revealed that a
metabolic syndrome rather than obesity itself is implicated in the
etiology of OA [3]. However, the reasons why there is such a cor-
relation between metabolic syndrome and OA remains elusive.
Adipose tissue has been characterized as an active endocrine
organ. The infrapatellar fat pad (IPFP) is a unique fat depot that is
located intracapsularly and extrasynovially in the joint and is in close
contact with articular cartilage. Recently, the endocrine function ofs Surgery, Tokyo Medical and
, 113-8519, Japan.
r Inc. This is an open access articlethe IPFP has been implicated in the initiation and progression of OA
[4]. We previously disclosed that the murine IPFP secretes inﬂam-
matory cytokines within twelve weeks of exposure to HFD [5]. This
model reveales that adipocyte hypertrophy closely links OA pro-
gression through secretion of inﬂammatory cytokines [5].
Ageing is also a pivotal risk factor for osteoarthritis. The stress-
response and chromatin-silencing factor Sir2, a yeast sirtuin, is a
NADþ-dependent histone deacetylase and is involved in controlling
ageing [6]. In mammals the sirtuin family contains seven genes
(SIRT1eSIRT7) encoding sirtuin proteins that differ in tissue spec-
iﬁcity, subcellular localization, enzymatic activity and targets.
Among them, SIRT6 is localized to the nucleus and is involved in
transcriptional silencing, genome stability, and longevity [7]. Sirt6
is implicated in the regulation of life span and ageing through the
regulation of NFkB function [7]. We previously disclosed that Sirt6
is expressed in chondrocytes and controls proliferation and differ-
entiation of chondrocytes through the regulation of Indian hedge-
hog (Ihh) expression [8]. These facts suggest possible roles of Sirt6
in the maintenance of the articular cartilage. However, the precise
role of Sirt6 in OA pathogenesis is poorly understood. This study
sought to investigate the involvement of Sirt6 in the ageing of
articular tissues and in the development of HFD-induced OA by
using a murine HFD-induced osteoarthritis model. Furthermore,
we compared the phenotype of the articular tissues between Sirt6under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cient mice to evaluate the critical roles of Sirt6 in the chondrocytes.
2. Materials and methods
2.1. Animals
All animal experiments were approved by the Animal Care and
Use Committee of Tokyo Medical and Dental University and were
carried out in accordancewith the approval guidelines. Sirt6 ±mice
on a 129X1/SvJ background were obtained from Jackson Laboratory
(Bar Harbor, ME, USA). Prx1-Cre (B6.Cg-Tg[Prx1-Cre]1Cjt/J) mice
were kindly supplied by Dr. Hiroshi Asahara. Sirt6f/f mice
(FVB.129S6(Cg)-Sirt6tm1.1Cxd/J) and Prx1-Cremicewere crossed to
generate Prx1-Cre; Sirt6f/þ mice, and their progeny were inter-
crossed to obtain Prx1-Cre; Sirt6f/f mice. The mice were sacriﬁced
and analyzed at six months of age. Sirt6 heterozygous mice
(Sirt6 ± mice) or littermate mice (WT mice) were fed a diet con-
taining 32% fat for the high fat diet group (HFD) or 4.8% fat for the
normal diet group (ND) (HFD32 and CE-2; CLEA Japan, Inc. Tokyo,
Japan) [23] from the age of six months. All of the animals were
allowed unrestricted activity and were provided food and water ad
libitum. None of the mice died during the experimental period.
2.2. Cell culture conditions
Primary epiphyseal chondrocytes were isolated from 5-day-old
mice as previously reported [24]. Brieﬂy, cartilage tissues, including
the femoral heads, femoral condyles and tibial plateau, were cut
into small pieces and digested twice for 45 min each with 3 mg/ml
type I collagenase. The cartilage pieces were then incubated in
0.5mg/ml type I collagenase at 37 C in a thermal incubator with 5%
CO2 overnight. The next day, cell aggregates were dispersed by
pipetting. The cells were cultured in 12-well plates seeded with
5  104 cells per well in DMEM/F12 medium containing 10% FBS
and antibiotics. The cells were transfected with 50 nM Sirt6 siRNA
or scrambled siRNA with HiPerFect (Qiagen, Valencia, CA, USA) in
medium supplemented with 10% FBS for 24 h. The target sequence
of Sirt6 siRNA was 50GAAGCUCCCAAUGCAAUAAAU30(forward) and
50UUAUUGCAUUGGGAGCUUCUG30 (reverse).
2.3. Assessment of OA severity
Sirt6 ±mice and the littermates were sacriﬁced at twelve weeks
after initiating the diet (n ¼ 7). Prx-1Creþ;Sirt6f/f mice (n ¼ 6) were
sacriﬁced at 6 months of age. Whole knee joints were removed by
dissection, ﬁxed in 4% paraformaldehyde, and decalciﬁed in EDTA.
After dehydration and parafﬁn embedding, serial 5-mm sagittal
sections were made from the whole medial compartment of the
joint as mentioned previously [5]. Quantitative osteophyte deter-
minationwas made as mentioned previously [5]. Brieﬂy, the medial
part of the sections, in which the central region of the medial
meniscus was continuous, were selected and the protruded region,
which stained green by Safranin-O staining, at the anterior edge of
the tibial plateau was deﬁned as bony osteophyte and quantiﬁed
using ImageJ software (Media Cybernetics, Carlsbad, CA). For the
evaluation of OA severity, representative sections were selected
from the medial tibial plateau and medial femoral plateau, and
scored with osteoarthritis research society international (OARSI)
scoring [25]. Two representative sections from each mouse were
blindly evaluated by three different readers.
2.4. Glucose tolerance test (GTT)
Mice were fasted overnight (18 h) before GTT was performed, byan intraperitoneal injection of glucose (0.5 g/kg; SigmaeAldrich, St.
Louis, MO) to assess glucose clearance. Blood samples were taken
from the tail vein before and 30, 60, 90 and 120 min following the
injection. Blood glucose level was measured using Glutest neo
alpha (Sanwa kagaku kenkyusho CO., LTD, Nagoya, Japan).
2.5. Immunohistochemistry
The protein expression of type X collagen (ColX), Matrix
Metalloproteinase-13 (MMP-13), Sirt6 and Plasminogen activator
inhibitor-1 (PAI-1) was determined by immunohistochemistry us-
ing anti-ColX antibody (LSL, Japan), anti- MMP-13 (Abcam Bio-
chemicals, Cambridge, UK), anti-Sirt6 (Abcam Biochemicals,
Cambridge, UK) and anti-PAI-1 (Abcam Biochemicals, Cambridge,
UK) respectively, according to the manufacturer's instructions. The
signal was visualized using peroxidase-conjugated avidin and
diaminobenzidine from a Vectastain kit, according to the manu-
facturer's instructions (Vector Laboratories, Burlingame, CA, USA).
2.6. TUNEL assay
Apoptotic cells in the articular cartilage were detected by a
TUNEL detection kit according to the manufacturer's instructions
(Takara Shuzo, Kyoto, Japan).
2.7. Statistical analysis
Data are expressed as the mean ± 1 SD. Statistical analysis was
performedwith theManneWhitney U test or TukeyeKramer test. P
values less than 0.05 were considered signiﬁcant.
3. Results
3.1. Impact of Sirt6 haploinsufﬁciency with or without HFD on the
insulin tolerance
Body weights of Sirt6 ± mice in 129X1/SvJ strains were com-
parable toWT littermates at six and nine months of age (Fig. 1a). To
investigate the role of Sirt6 in obesity-induced OA, Sirt6 ±mice and
the littermates were fed HFD or normal diet (ND) for three months
from 6 months of age. Both WT and Sirt6 ± mice fed the HFD
weighed 20%more after twelve weeks on the diet (Fig. 1a, p > 0.05).
To evaluate the limb mesenchymal cell-speciﬁc function of Sirt6,
we developed the conditional Sirt6 deletion mice carrying ﬂoxed
Sirt6 alleles bred with Prx1-cre transgenic mice (Prx-1Cre;Sirt6f/f
mice). Body weights of Prx-1Cre;Sirt6f/f micewere comparable to the
controls at six months of age (Fig. 1a). To explore the role of Sirt6
insufﬁciency in glucose homeostasis and insulin sensitivity, glucose
tolerance tests (GTTs) was performed for WT and Sirt6 ± mice
(Fig. 1b). In ND group, fasting blood glucose level was lower in
Sirt6 ± mice at 90 and 120 min following glucose injection than in
WT mice (Fig. 1(b)a). However, after being fed HFD for 12 weeks,
Sirt6 ±mice showed signiﬁcantly higher blood glucose levels at 30
and 60 min following glucose injection as compared to those in the
other littermates (Fig. 1(b)b). These data suggest that Sirt6 ± mice
fed an HFD were more susceptible to metabolic syndrome thanWT
mice.
3.2. mRNA proﬁles in the IPFP
Although Sirt6 overexpression has been reported to have pro-
tective roles against diet-induced metabolic diseases [9], the roles
of Sirt6 in the fat tissue depot response to HFD have yet to be
elucidated. Thus we monitored the mRNA expression levels of in-
ﬂammatory cytokines/adipokines of the IPFP at sacriﬁce. Real-time
Fig. 1. Body weight and serum concentration of adipokines. (a); Body weight of WT and Sirt6 ± mice fed indicated diets in indicated ages. (b) Effect of Sirt6 haploinsufﬁciency on
glucose tolerance in mice fed a HFD or ND for 12 weeks (n ¼ 8 per group). (c); real time RT-PCR analysis of the IPFP for Leptin, TNF-a and IL-6 in the indicated mice. (d) Sirt6 mRNA
expression in the articular chondrocyte and the IPFP in Prx-1Cre;Sirt6f/f mice. * ¼ P < 0.05 using the ManneWhitney U test or TurkeyeKramer test.
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such as TNF-a and IL-6, were spontaneously enhanced in the IPFP in
Sirt6 ± mice whereas this effect was not observed in Prx-1Creþ;Sirt6f/f mice (Fig. 1c). When Sirt6 ± and the littermate mice
were fed HFD, leptin mRNA was similarly increased in the IPFP
(Fig. 1c). The expression of TNF-a and IL-6 in the IPFP was the
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in the chondrocytes of Prx-1Cre;Sirt6f/f mice, whereas the expres-
sion level of Sirt6 in the IPFPwas comparable in thesemice (Fig.1d).
3.3. Histological analysis of the femorotibial joints
Next, the knee joints were histologically investigated. Histo-
logical investigation of the femorotibial joints of nine-month-old
mice frequently revealed vertical clefts down to the layer imme-
diately below the superﬁcial layer in association with moderate
reduction of Safranin-O intensity only in Sirt6 ± mice (Fig. 2a).
When HFD was applied to these mice, the histological features of
OA were observed both in WT and Sirt6 ± mice, although the his-
tological alterationwas more apparent in Sirt6 ±mice (Fig. 2a). The
OA severity based on OARSI score indicated Sirt6 ± mice scored
higher compared to WT littermates (Fig. 2b). Safranin-O staining
revealed glycosaminoglycan (GAG) concentration was markedly
reduced in Prx-1Cre;Sirt6f/f mice (Fig. 2a). When Sirt6 was knocked
down in the epiphyseal primary chondrocyte by Sirt6 siRNA,
aggrecan transcript was signiﬁcantly suppressed (Fig. 2c). These
results indicated Sirt6 was required for the expression of glycos-
aminoglycan in the articular cartilage.
3.4. Immunohistological analysis for OA markers
We next evaluated the expression of the markers of OA in
articular cartilage by immunohistochemistry (Fig. 2d, f). Staining
for type X collagen (ColX), an extracellular matrix marker for
chondrocyte hypertrophy, was enhanced at the deep layer of the
articular cartilage in WT HFD, Sirt6 ± ND, and Sirt6 ± HFD groups
(Fig. 2d). The expression of MMP-13, a matrix protease implicated
in the OA process, was also signiﬁcantly increased at the superﬁcial
layer of articular cartilage in Sirt6 ± ND and Sirt6 ± HFD groups
compared to WT or control, respectively (Fig. 2f, g). On the other
hand, ColX expression and the number of hypertrophic chon-
drocytes were reduced in Prx-1Creþ;Sirt6f/f mice (Fig. 2d, e).
Furthermore, the expression of MMP-13 in Prx-1Creþ;Sirt6f/f mice
was similar compared to the control mice (Fig. 2f). These ﬁndings
indicated endogenous Sirt6 deletion in the chondrocytes did not
accelerate the expression of MMP-13 and ColX.
Osteophyte formation is among the characteristic features of OA.
Sirt6 haploinsufﬁciency was associated with enhanced osteophyte
formation at the anterior edge of the sagittal section of the tibial
plateau, whereas osteophytes were hardly observed inWTNDmice
(Fig. 3a, b, c). Simultaneously, hypertrophy of the synovium
accompanied by inﬁltration of inﬂammatory cells (Fig. 3c arrows)
was also enhanced in the Sirt6 ± ND (Fig. 3c, d, e). The osteophyte
formation was further enhanced by HFD in Sirt6 ±mice (Fig. 3a, b)
in association with further hypertrophy of the synovial tissues
(Fig. 3c, d, e). These ﬁndings suggested inﬂammation triggered by
global haploinsufﬁciency of Sirt6 was further enhanced by HFD.
3.5. Chondrocyte apoptosis and senescence
Chondrocyte apoptosis is increased in OA cartilage and is
anatomically linked to proteoglycan depletion [10]. The number of
TUNEL positive cells was elevated by HFD in WT and Sirt6 ± mice
(Fig. 4a, b). Furthermore, Sirt6 ± mice exhibited spontaneous
increased apoptotic cells even in the ND group (Fig. 4a, b). On the
other hand, in Prx-1Creþ;Sirt6f/f mice, TUNEL positive cells were not
increased in the articular cartilage (Fig. 4a, b). To address the role of
Sirt6 in articular chondrocyte senescence, the expression of PAI-1
protein was evaluated by immunohistochemistry. PAI-1 positive
chondrocytes were rarely observed in 2-month-old mice (Fig. 4d).
Both Sirt6 ± mice at 9 months of age and Prx-1Creþ;Sirt6f/fdemonstrated higher levels of PAI-1 expression (Fig. 4c, d). The HFD
caused a more notable increase in PAI-1 expression in Sirt6 ±mice.
PAI-1 expression in the chondrocytes was signiﬁcantly increased in
WT aged mice (Fig. 4c, d), suggesting that PAI-1 expression in
chondrocytes increases with age. These results indicates enhanced
PAI-1 expression in Sirt6 ± mice and Prx-1Creþ;Sirt6f/f mice may
mimic the ageing process of the joint cartilage.
4. Discussion
Here we revealed the roles of Sirt6 in the etiology of metabolic
syndrome, including osteoarthritis. First, Sirt6 haploinsufﬁciency
promoted the expression of inﬂammatory cytokines in the IPFP in
association with impaired glucose tolerance. With the background
of 129sv, we performed a glucose tolerance test (GTT) on wild-type
(WT) and Sirt6 ± mice. The 129 strain is reported to develop fea-
tures of metabolic syndrome, such as obesity, hyperinsulinemia,
and glucose intolerance, after being fed a high-fat diet (HFD) for
over 18 weeks [11]. From the result of our GTT, we conﬁrmed
Sirt6 ± mice were more susceptible to metabolic syndrome after
being fed HFD.
Second, enhanced inﬂammation of the IPFP was associated with
accelerated OA progression in Sirt6 ± mice. In Sirt6 ± mice,
advanced degeneration of the articular cartilage (Fig. 2) and
increased apoptosis (Fig. 4a, b) were observed, in many cases,
irrespective of administration of HFD. In Sirt6 ± mice, the expres-
sion level of inﬂammatory cytokines increased in the IPFP (Fig. 1c).
Whereas TNF-a and IL-6 induce apoptosis in chondrocytes, we
previously reported Sirt6 had no effect on chondrocyte apoptosis
[8]. This phenotype is consistent with that of Prx-1Creþ;Sirt6f/fmice,
in which TUNEL positive cells were not increased in the articular
chondrocytes (Fig. 4a). The enhancement of the inﬂammatory cy-
tokines in the IPFPwas observed only in Sirt6 ±mice and not in Prx-
1Creþ;Sirt6f/f mice, as Sirt6 expression was comparative in the IPFP
of Prx-1Creþ;Sirt6f/fmice (Fig. 1d). The expression levels of ColX and
MMP13 were also spontaneously enhanced in Sirt6 ± mice, in
which the expression of TNF-a was enhanced in the IPFP. TNF-a
induces IL-6 mRNA in OA chondrocytes [12]. Treatment of OA
chondrocytes with IL-6 results in enhanced production of MMP-13
protein [12]. In contrast, in Prx1cre;Sirt6f/f mice, the expression
levels of ColX and MMP13 were decreased or unaffected. In our
previous study, we revealed Sirt6 deletion inhibits the expression
of ColX through the inhibition of Indian hedgehog (Ihh) by sup-
pressing the afﬁnity of ATF4 to the Ihh promoter [8]. This result is
consistent with the aforementioned inhibition of ColX expression
in Prx1cre;Sirt6f/f mice. Given that positive regulation of MMP13
expression by Ihh was previously reported [13], we believe that Ihh
is also likely to contribute to the unchanged MMP13 expression in
Prx1cre;Sirt6f/f mice. Considering these facts, the increased ColX,
MMP-13 expression and apoptotic activity in Sirt6 ± chondrocytes
may be caused by enhanced IPFP inﬂammation and not as the result
of chondrocyte cell autonomous regulation.
When Sir6 ± mice were fed HFD, an increase was observed in
osteophyte and synovium formations (Fig. 3a), in addition to a
further increase in the expression level of the cartilage degenera-
tion marker MMP13 (Fig. 2f, g). These ﬁndings imply that the
expression levels of inﬂammatory cytokines such as TNF-a and IL-6
in the IPFP are higher in HFD-fed Sirt6 ± mice than in ND-fed
Sirt6 ± mice. In other words, the co-existence of Sirt6 hap-
loinsufﬁciency and obesity worsens the inﬂammation in the IPFP.
The IPFP contains adipocytes and immune cells such as lym-
phocytes, monocytes and granulocytes [14]. The IPFPs from OA
patients contain increased amounts of inﬂammatory cytokines [15].
Thus, the IPFP has been shown to play an important role in the
initiation and progression of knee-OA. Overexpression of SIRT6 in
Fig. 2. Histological analysis of Sirt6 mutants and WT mice with normal diet and high fat diet. (a); Sections of articular cartilage from indicated genotypes, diets stained with
Safranin-O. (b) OA severity of medial tibial plateau based on OARSI scoring for mice. (c) mRNA expression of aggrecan in the epiphyseal primary chondrocyte of Sirt6 knocked down
and the control. (d, f); Immunostaining for ColX (d) and MMP-13 (f) in the knee joint of indicated genotypes and diet. (e) The number of hypertrophic chondrocytes at the deep layer
of tibial cartilage of indicate genotypes. (g) The number of MMP-13 positive chondrocytes at the superﬁcial layer of the joint cartilage in the indicated genotypes and diets. Scale bar:
100 mm. Values are the mean ± 1 SD of ﬁve mice per group. * ¼ P < 0.05 the TurkeyeKramer test or the ManeWhitney U test.
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Fig. 3. High magniﬁcation of the anterior edge of the medial tibial plateau in the HFD and the control diet mice at twelve weeks after the diet initiation. (a, c) Representative
Safranin-Ostained sections (a) and HE-stained sections (c). (b, d, e) Quantiﬁcation of osteophytes (b), synovial cells (d) and synovial tissue area (e) at anterior edge of tibial prateau of
indicated genotypes and diets. (a, c) Arrowheads represent osteophytes developed at the anterior edges of the medial tibial plateau. Arrows represent synovial tissues. Scale bar:
100 mm. Values are the mean ± 1 SD of ﬁve mice per group. * ¼ P < 0.05 with the TurkeyeKramer test or the ManeWhitney test.
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by HFD-induced obesity [16]. Many inﬂammatory cytokines,
including TNF-a, are implicated in HFD-induced inﬂammation of
the fat tissues. TNF-a is produced by macrophages, lymphocytes,and also by adipose tissue, although its expression level is relatively
low in humans [17]. Thus, locally present macrophages may play
important roles in the elevated expression levels of these cytokines.
Macrophages derived from the bonemarrowof Sirt6-deﬁcientmice
Fig. 4. (a, b); TUNEL staining for the femorotibial joints (a) and the number of TUNEL positive cells in the superﬁcial layer of articular cartilage (b) of indicated genotypes and diets.
(c, d); Immunostaining for PAI-1 in the tibial plateau (c) and the rates of PAI-1-positive cells per all the chondrocytes in the superﬁcial layer of the articular cartilage (d) of indicated
genotypes and diets. Scale bar: 100 mm. Values are the mean ± 1 SD of ﬁve mice per group. * ¼ P < 0.05 vs 2 mWT; ND, ** ¼ p < 0.05 vs 18mo-WT; ND with the TurkeyeKramer test
or the ManeWhitney U test.
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hypersensitive to LPS stimulation through activation of c-JUN
signaling [18]. Furthermore, Sirt6 was reported to directly promote
the secretion of TNF-a by removing the fatty acyl modiﬁcation of
TNF-a [19]. Combined with our data, Sirt6 may function as an anti-
inﬂammatory factor in the course of HFD-induced OA development
through the action on the macrophages in the IPFP.
Third, we demonstrated PAI-1 protein expression was domi-
nantly observed at the superﬁcial layer of the articular chon-
drocytes of Sirt6 ±mice. Consistently, PAI-1 expression is increased
in the human OA cartilage [20]. We previously reported the
expression of senescence marker genes are increased in epiphyseal
chondrocytes fromyoung Sirt6/mice [8]. Senescent cells secrete
inﬂammatory cytokines as a result of a behavior termed the
senescence-associated secretory phenotype (SASP) [21]. We pre-
viously revealed the expression of these cytokines was enhanced in
Sirt6/ chondrocytes [8]. Considering the fact that the SASP
contributes to the onset of osteoarthritis [22], we believe that, in
aged mice, increased expression of PAI-1 in chondrocytes contrib-
utes to the progression of knee osteoarthritis. Thus, in the normal
diet groups, both increased inﬂammation in the IPFP and increased
PAI-1 expression in chondrocytes contributed to the progression of
cartilage degeneration in Sir6 ± mice.
In conclusion, our results provide clues that Sirt6 prevents
articular cartilage degradation and IPFP inﬂammation caused by
metabolic syndrome. We believe these ﬁndings imply that, in
humans, the risk of knee osteoarthritis increases as the level of Sirt6
activity decreases with age and that the combination of senility and
obesity makes the elderly more susceptible to the worsening of
knee osteoarthritis as compared to the young. These results support
a potential therapeutic application of a SIRT6 agonist in the IPFP in
human OA.
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